These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Defective phospholipase D activation in Ki-ras-transformed NIH3T3 cells: evidence for downstream effector of PLC-gamma 1 in PDGF-mediated signal transduction.
    Author: Alam MS, Banno Y, Nakashima S, Nozawa Y.
    Journal: Biochem Biophys Res Commun; 1995 Feb 06; 207(1):460-6. PubMed ID: 7531974.
    Abstract:
    Platelet-derived growth factor (PDGF), a potent mitogen for fibroblasts and many other cell types, was used to examine phosphatidylcholine-specific phospholipase D (PLD), phosphoinositide-specific phospholipase C (PI-PLC) and tyrosine phosphorylation in NIH3T3 fibroblast and its Ki-ras-transformed derivative, DT. When cells prelabeled with [3H] myristic acid were stimulated by 10 and 50 ng/ml of PDGF in presence of 0.3% butanol, formation of phosphatidylbutanol (PtdBut) was increased three to six fold in NIH3T3 fibroblasts whereas it was marginal in DT cells. Myo-[3H]inositol-labeled cells showed higher inositol phosphate production in nontransformed control fibroblasts, indicating higher phospholipase C activity compared to the transformed DT cells. PDGF caused increase in tyrosine phosphorylation of a group of proteins with 110-130 kDa, PLC-gamma 1 and PDGF receptor in NIH3T3 cells. There was no significant increase in tyrosine phosphorylation in both PDGF receptor and PLC-gamma 1 in DT cells. These results suggest that PLD acts as a downstream effector molecule of PLC-gamma 1 in the PDGF-mediated signal transduction pathway.
    [Abstract] [Full Text] [Related] [New Search]